Once-Daily Oral Semaglutide Versus Injectable Glp 1 RAs in People With Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-Analysis
figureposted on 2021-03-05, 12:29 authored by Adis journals on behalf of, Barrie Chubb, Palvi Gupta, Jatin Gupta, Solomon Nuhoho, Klaus Kallenbach, Michelle Orme
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.